Imaging News

Among people aged 55 years or older who had a high burden of coronary atherosclerosis, women were at greater risk for a major adverse cardiovascular event than men, researchers reported.

A deep neural network demonstrated good discrimination of reduced left ventricular ejection fraction using angiogram videos compared with transthoracic echocardiogram, researchers reported.

Ultromics announced it has received FDA breakthrough device status for its artificial intelligence-enhanced platform for detecting cardiac amyloidosis on echocardiograms.

The antiarrhythmic benefits of empagliflozin in patients with and without diabetes may be explained by the SGLT2 inhibitor’s ability to improve left atrial strain reservoir and contraction phase values, researchers reported.

Assessing the effect of evolocumab (Repatha, Amgen) on coronary plaque morphology using intravascular imaging and gene expression analysis in people with stable CAD on maximally tolerated statin therapy.

The American College of Cardiology Scientific Session featured three late-breaking clinical trials of particular interest to the sports cardiology and hypertrophic cardiomyopathy communities.

PCSK9 inhibition with alirocumab, on top of high-intensity statin therapy, resulted in significant coronary plaque regression among patients with familial hypercholesterolemia and no clinical atherosclerotic CVD, researchers reported.

The FDA has granted 510(k) clearances to seven triage and notification findings of varying conditions on chest X-ray and head CT images, according to a manufacturer-issued press release.

Medtronic announced it has launched a website and app to help health care providers reduce potential delays in the cardiac MRI scan workflow.

The American College of Cardiology Scientific Session was held March 4 to 6 in New Orleans. Healio | Cardiology Today was on-site for the latest news in cardiology and experts’ reactions to it.